Aerovate Therapeutics, Inc. (AVTE) Misses Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts AVTE Hot Sheet
Join SI Premium – FREE
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) reported Q1 EPS of ($0.67), $0.10 worse than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Aerovate Therapeutics, Inc. (AVTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genesco (GCO) Tops Q2 EPS by 54c ; Offers Guidance
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
- Five Below raises full-year outlook after strong second-quarter sales growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
